Home » PDTA BETA THALASSEMIE: THE DAY HOSPITAL OF CONA HOSPITAL OBTAINS ISO 9001 CERTIFICATION

PDTA BETA THALASSEMIE: THE DAY HOSPITAL OF CONA HOSPITAL OBTAINS ISO 9001 CERTIFICATION

by admin

The Diagnostic Therapeutic Assistance Path – PDTA – “Beta Thalassemia” of the Day Hospital of Thalassemia and Hemoglobinopathies (DHTE) was recently certified ISO 9001. “It deals with – explains the Dr. Filomena Longo, Director of the DHTE of the Cona hospitalof a procedure That guarantees the quality standard and allows us to optimize internal processes and improve operational efficiency and the quality of care for our patients”.

THE DTHE OF FERRARA.

The history of thalassemia treatment in Ferrara begins more than 50 years ago. Over the years this severe hereditary anemia has transformed from ‘exclusively pediatric pathology with fatal outcome’ to ‘chronic disease’ with life expectancy increasingly close to that of the general population. This was possible thanks to the improvement of care (safer transfusion protocols, widespread use of iron chelation, monitoring of iron accumulation and management of complications) which have always been guaranteed by the Ferrara Center dedicated to these patients. The DHTE ensures complete and qualified assistance to pediatric and adult patients with thalassemia and haemoglobinopathies. Highly complex treatments are provided as part of the diagnosis, therapy and follow-up of the disease. The key figures mainly involved are: the paediatrician, the haematologist and the internist who have the important task of maintaining a global vision of the patient and his problems and of coordinating a multidisciplinary approach which includes many actors (endocrinologist, cardiologist, hepatologist, ophthalmologist, transfusionist, radiologist, etc.). The involvement of different specialists allows us to address the complex clinical aspects and challenges that patients with thalassemia may face throughout their lives.

In the last year, 447 patients were followed at the DHTE. Approximately 200 patients (51% women) with thalassemia major transfuse regularly at the DHTE. The Center also takes care of people with other forms of thalassemia and hemoglobinopathies, such as sickle cell disease. Over 50% of the patients referred to the Center come from other Regions and some even from abroad.

The PDTA for thalassemia it is a standardized path, developed by a multidisciplinary team of experts, which takes into account the best available clinical evidence. The application of PDTA guarantees the patientcontinuous and coordinated assistance by all the professionals involved in your treatment path.

See also  Chronic or recurrent fatigue, weakness and exhaustion could be some alarm bells of these 5 common diseases, here's how to recognize them

Accurate documentation of procedures – concludes Dr. Longo –the constant monitoring of performance and the involvement of the DHTE staff as well as patient associations such as “ALT Rino Vullo” of Ferrara, have made it possible to obtain ISO 9001 certification for the Thalassemia and Haemoglobinopathies Day Hospital”.

I’m very proud – declares the Dr. Monica Calamai, General Director of the Ferrara Healthcare Companiesfor this important recognition obtained by our Center for Thalassemia, which is not only a Hub in our Emilia-Romagna region, but also a national reference. It is a service with a long and significant history, carried forward also thanks to the precious contribution of the Director, Dr. Longo. I would also like to highlight how the path – multidisciplinary and multiprofessional that led to certification – had particular attention to gender medicine, a very important topic for the two provincial health authorities that have been working for some time to achieve gender certification, which we should be close to achieving. This recognition is certainly part of a series of excellences that we have within our healthcare and, for this reason, I would like to thank all the professionals who, in various capacities, are involved in the Paths which have the aim of always offering services and performances more qualified and accessible for patients”.

I thank all the staff – highlights the prof. Marcello Govoni, Director of the Department of Specialist Medicinefor the great work that has been done. The certification of a PDTA tells us that the activity carried out by our professionals has followed criteria of rigor and scientific method, with the aim of offering the best service to our patients and this is extremely important for us. The attention to Thalassemia in this hospital began many years ago and Today we can say that culture, knowledge and everything that revolves around this serious pathology is the fruit of a scientific commitment that has grown over time and that has found a way to express itself, certainly in a more rigorous way, but with unchanged enthusiasm by Dr. Longo’s team”.

See also  Delirium of doctors: less treatment, they pollute

OPT – SOLUTIONS FOR THE HEALTHCARE WORLD, President Dr. Oreste Pitocchi and Principal Consultant and Head of Quality and Certification Area Dr. Gaia Navarra.

The ISO 9001 certification path of PDTA Beta Thalassemia represents one best practice within the organization and a concrete and continuous commitment to improvement for all the actors involved. In particular, through certification, the PDTA Beta Talassemie intends to guarantee:

– maintaining the quality standards of the services provided;

– the appropriateness of the routes;

– equity of access and homogeneous standards in the provision of increasingly personalized healthcare services;

– multidisciplinary and multi-professional management through a dedicated team which, in full synergy, defines in a coordinated manner the optimal path for each individual patient, from diagnosis to follow up.

The methodological approach implemented during certification made it possible to go beyond the formalization of the PDTA document, rather embracing the entire model of governance on the pathology for the benefit of the entire organization and the patient, further enhanced and validated by a Certification by the CSQA Certification Body according to the international quality standard ISO 9001.

The adoption of a certified PDTAdeclares Gaia Navarraoffers patients the guarantee of being able to count on timely care, an efficient, innovative and updated therapeutic offer and a multidisciplinary team of highly qualified specialists at every stage of the treatment process. Obtaining the ISO 9001 certification represented for the Center not only a well-deserved and prestigious achievement, but also the opportunity to learn and apply a method which makes the analysis of processes and the comparison between different professionalisms the distinctive characteristics for activating a virtuous cycle of continuous improvement”.

CSQA CERTIFICATION BODY, General Director and CEO Dr. Pietro Bonato.

We are very satisfied to be able to witness and deliver the certification of this PDTA in person That makes clear the attention towards patients and interested parties on the pathology of Beta Thalassemia, guaranteeing the paths that accompany the patient in the diagnosis and treatment process. CSQA, as a publicly controlled certification body – the only one of its kind – guarantees the application of scientific evidence, communication between team members, patients and caregivers, coordination of the assistance, the evaluation of outcomes and the appropriateness of resources”.

GISEG – ITALIAN HEALTH AND GENDER GROUP – and IMG – GENDER MEDICINE, President Prof. Annamaria Moretti.

“Recognizing and valuing gender differences allows us to provide appropriate care: this concept underlines the need to set policies aimed at increasing effective strategies to address gender inequalities in health services and guarantee people the best care. This perspective was also applied to the PDTA Beta Thalassemia certification process”.

“’Gender medicine’ constitutes Today a real change of culture in the approach to the patient and a new challenge to medical knowledge, built not only in the context of biological differences, but also from the perspective of social, economic, cultural and religious differences. If, in fact, at the beginning he only considered the different clinical expression of diseases between men and women, Today there are numerous parameters for interpreting the differences. The evaluation of such sex and gender differences constitutes Today a fundamental element for the development of ‘fair, appropriate and inclusive medicine’ and the use of specific indicators must also constitute an integral part of research, training and communication programmes. The relationship between the impact of disease and local and hospital healthcare organization constitutes a fundamental element of reflection. It is therefore important that institutions develop programs for knowledge, training and promotion of health and disease prevention, invest in primary care systems, transfer health care to the territory, strengthening outpatient and home care that is more accessible and less expensive, with particular attention to the relationship between gender indicators and social sustainability. The gender dimension in health is therefore a need for method and analysis which will soon, we hope, become an instrument of government and health planning”.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy